IMMUCELL CORP /DE/·4/A

Dec 4, 4:11 PM ET

te Boekhorst Paul Francis Olivier 4/A

4/A · IMMUCELL CORP /DE/ · Filed Dec 4, 2025

Insider Transaction Report

Form 4/AAmended
Period: 2025-12-03
te Boekhorst Paul Francis Olivier
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock $0.10 par value per share

    2025-12-03$5.04/sh+3,598$18,1527,306 total
  • Purchase

    Common Stock $0.10 par value per share

    2025-12-04$5.50/sh+2,432$13,3769,738 total
Footnotes (2)
  • [F1]This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased.
  • [F2]This amendment amends the previously reported transaction effective on 12/3 to disclose the correct amount and price of shares purchased, and the correct transaction date.

Documents

1 file
  • 4
    rdgdoc.xml

    FORM 4/A OLIVIER TE BOEKHORST